Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
By C. Staatz, S. Tett. Clinical Pharmacokinetics, 2004
908 citations recorded by the source corpus.
Subfields: Oncology, Pediatrics, Perinatology and Child Health, Transplantation
View Paper: https://www.semanticscholar.org/paper/c582f5e9900f26e3e9701f18effb415127fbd983
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- K. Caudle
- K. Birdwell
- B. Decker
- C. M. Stein
- Julia M. Barbarino
- J. F. Peterson
- J. S. Leeder
- T. Klein
Citations in the corpus
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing (2015, background): “This has been extensively reviewed in an article by Staatz and Tett.(38) Additional genetic variants described in the literature but with unclear effects on tacrolimus metabolism because of either limited or conflicting studies include CYP3A4*22, POR*28, PPAR alpha, and ABCB1.”